Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;7 Spec No. 2(Spec Iss 2):71-5.

Visual acuity outcome in patients with diabetic maculopathy

R Serban  1 , M Cioboata  1 , C Chiotan  2 , C Cornăcel  1 , R Liora  1 , A Anghelie  1
Affiliations

Visual acuity outcome in patients with diabetic maculopathy

R Serban et al. J Med Life. 2014.

Abstract

The purpose of this study is to follow up visual acuity in patients diagnosed with clinically significant macular edema and treated by an intravitreal injection of triamcinolone acetonide or in combination with bevacizumab. The working method: based on the selectivity criteria we involved 295 patients (460 eyes), divided into 2 groups according to the treatment administered and one control group. The results showed a better preservation of the functional parameter for the group of patients treated with intravitreal injection of triamcinolone acetonide and bevacizumab.

Keywords: Diabetic Maculopathy; Triamcinolone acetonide; Visual acuity; bevacizumab; clinically significant macular edema.

PubMed Disclaimer

References

    1. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative and angiogenic diseases. Prog Ret Eye Res. 2005;5:587–611. - PubMed
    1. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920–927. - PubMed
    1. Duh E. Diabetic Retinopathy. Humana Press; 2008.
    1. Audren F, Tod M, Massin P, Benosman R, Haouchine B, Erginay A, Caulin C, Gaudric A, Bergmann JF. Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema. Invest Ophthalmol Vis Sci. 2004;45:3435–3441. - PubMed
    1. Bandello F, Pognuz DR, Pirracchio A, Polito A. Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2004;242:1024–1027. - PubMed

MeSH terms

LinkOut - more resources